Trials / Completed
CompletedNCT01705704
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B
An Exploratory Evaluation of Interleukin 28B (IL28B) Genotype, Single Nucleotide Polymorphisms (SNP) of rs12356193, Protein and RNA Biomarkers in Serum Samples (Stored, Already Obtained From Completed Studies) From Subjects With HBe-antigen Positive or Negative Chronic Hepatitis B, Who Have Completed Therapy for Hepatitis B With Pegasys ± Lamivudine.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 269 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective study will evaluate the association of biomarkers and the treatment response of patients with chronic hepatitis B, who have completed therapy with Pegasys (peginterferon alfa-2a) ± lamivudine. For the analysis stored serum samples obtained from patients will be used; no actual patients are involved.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-10-12
- Last updated
- 2016-11-02
Locations
27 sites across 10 countries: Australia, France, Hong Kong, Italy, New Zealand, Russia, Singapore, South Korea, Taiwan, Thailand
Source: ClinicalTrials.gov record NCT01705704. Inclusion in this directory is not an endorsement.